← Leaderboards
John Stephen Lodmell
University Of Montana
$3,829,592
Attributed
$3,829,592
Total exposure
7
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $432.4K · FY2005–25$500K$375K$250K$125K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,829,592 · 7
By mechanism
R01$1,534,972 · 1
U54$1,191,717 · 1
R15$432,368 · 1
R03$430,866 · 3
R21$239,669 · 1
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Viral”
- Lawrence Corey · Fred Hutchinson Cancer Center$466,994,927
- David Heimbrook · Leidos Biomedical Research, Inc.$366,090,791
- Daniel R Kuritzkes · Brigham And Women'S Hospital$267,074,199
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$252,763,614
- Judith S. Currier · University Of California Los Angeles$185,434,785
- Constance Ann Benson · University Of California, San Diego$165,517,633
Research focus
ViralVirus ReplicationVirusVirus DiseasesRift Valley Fever VirusProteinsCell Culture TechniquesBiochemicalCessation Of LifeAfricaSignal TransductionPathogenAntiviral AgentsAffectIn VitroSymptomsLeadTranscriptRna SplicingBaseAffinityRna SequencesBinding (Molecular Function)Nucleocapsid Proteins
Grant awards (18)
Characterization of a ubiquitin binding domain in interferon pathway protein RIOK3$143,094
R03 · FY2025 · AI · contact PI
A role for snoRNAs in RVFV-induced enhancement of alternative splicing$72,500
R03 · FY2020 · AI · contact PI
Role of the atypical protein kinase RIOK3 in the cellular antiviral response$142,772
R03 · FY2019 · TR · contact PI
A role for snoRNAs in RVFV-induced enhancement of alternative splicing$72,500
R03 · FY2019 · AI · contact PI
Mechanism of RVFV nucleocapsid targeting drugs$432,368
R15 · FY2014 · AI · contact PI
Characterization and targeting rift valley fever virus N protein-RNA interactions$290,444
U54 · FY2013 · AI · contact PI
Characterization and targeting rift valley fever virus N protein-RNA interactions$282,747
U54 · FY2011 · AI · contact PI
Characterization and targeting rift valley fever virus N protein-RNA interactions$315,915
U54 · FY2010 · AI · contact PI
Characterization and targeting rift valley fever virus N protein-RNA interactions$302,611
U54 · FY2009 · AI · contact PI
HIV Genomic RNA Structure$224,928
R01 · FY2008 · AI · contact PI
HIV Genomic RNA Structure$229,030
R01 · FY2007 · AI · contact PI
HIV Genomic RNA Structure$235,347
R01 · FY2006 · AI · contact PI
HIV Genomic RNA Structure$100,197
R01 · FY2005 · AI
HIV-2 Genomic RNA Structure$239,669
R21 · FY2004 · AI
HIV-2 GENOMIC RNA STRUCTURE$182,030
R01 · FY2003 · AI
HIV-2 GENOMIC RNA STRUCTURE$176,541
R01 · FY2002 · AI
HIV-2 GENOMIC RNA STRUCTURE$174,806
R01 · FY2001 · AI
HIV-2 GENOMIC RNA STRUCTURE$212,093
R01 · FY2000 · AI